| K-number | K252649 |
| Device name | TAP2D |
| Applicant | Nano-X Imaging , Ltd. |
| Product code | IZF |
| Device class | Class II |
| Decision date | Feb 2, 2026 |
| Decision | Substantially Equivalent |
| Regulation | 892.1740 |
TAP2D is a cloud-based software accessory for Nanox.ARC X and Nanox.ARC tomosynthesis systems that provides a supplemental enhanced 2D view image in DICOM format extracted from the acquired DTS study. It is intended to assist radiologists when evaluating diagnostic tomosynthesis studies by presenting an enhanced, high-contrast single 2D projection image alongside the diagnostic DTS series without altering the original data.
TAP2D is a software-only post-processing module (SaMD) deployed in Nanox.CLOUD infrastructure with no image acquisition capability, user interface, or manual activation required. It differs from the predicate Nanox.ARC X hardware-based acquisition system by operating automatically and producing only a supplemental 2D output rather than controlling hardware, but both use the same cloud processing location and DICOM format.
Not stated in this summary.
TAP2D is substantially equivalent to Nanox.ARC X because it functions as an automatic post-processing accessory that produces a supplemental output from existing predicate device data without altering the predicate's functionality, raw data, or clinical performance. Both devices operate within the same clinical scope and workflow; TAP2D introduces no new clinical claims, safety concerns, or effectiveness questions, as confirmed by software verification, system performance testing, image quality assessment, and independent radiologist clinical validation.
View the full FDA submission: accessdata.fda.gov